Products - Merck Connect
PIFELTRO™ (doravirine 100 mg) tablets and DELSTRIGO™ (doravirine 100 mg/lamivudine 300 mg/tenofovir disoproxil fumarate 300 mg) tablets Before prescribing PIFELTRO, please read the accompanying Prescribing Information.
Actived: Wednesday Feb 24, 2021
Samples, Vouchers, and Coupons for JANUMET® (sitagliptin
JANUMET and JANUMET XR are contraindicated in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] below 30 mL/min/1.73 m 2); acute or chronic metabolic acidosis, including diabetic ketoacidosis; or history of a serious hypersensitivity reaction to JANUMET, JANUMET XR, sitagliptin, or metformin, such as anaphylaxis or angioedema.
Samples and Coupons for SIVEXTRO® (tedizolid phosphate)
Samples, Vouchers & Coupons. Samples: Receive a 200 mg sample tablet of SIVEXTRO. A 1-tablet (200 mg) package sample of SIVEXTRO is available for your appropriate patients with ABSSSI. If you would like to receive samples of SIVEXTRO, additional product information, or professional support, contact the Merck National Center. Merck National Center
Efficacy of NEXPLANON® (etonogestrel implant) 68 mg
Indication NEXPLANON is indicated for use by women to prevent pregnancy. Selected Safety Information Contraindications. NEXPLANON should not be used in women who have known or suspected pregnancy; current or past history of thrombosis or thromboembolic disorders; liver tumors, benign or malignant, or active liver disease; undiagnosed abnormal genital bleeding; known or suspected breast cancer
The Follistim Pen - Merck Connect
CONTRAINDICATIONS. FOLLISTIM AQ Cartridge is contraindicated in women who exhibit any of the following: prior hypersensitivity to recombinant human follicle-stimulating hormone (hFSH) products; high levels of FSH indicating primary gonadal failure; presence of uncontrolled non-gonadal endocrinopathies (eg, thyroid, adrenal, or pituitary disorders); hypersensitivity reactions to streptomycin or
Insertion and Removal for NEXPLANON® (etonogestrel implant
Insertion time. In a clinical trial, mean insertion time was <1 minute (27.9 ± 29.3 seconds). Insertion time was measured from the removal of the protective cap of the applicator until the retraction of the needle from the arm.
Dosing for BRIDION® (sugammadex) | Official Site
BRIDION is contraindicated in patients with known hypersensitivity to sugammadex or any of its components. Hypersensitivity reactions that occurred varied from isolated skin reactions to serious systemic reactions (i.e., anaphylaxis, anaphylactic shock) and have occurred in patients with no prior exposure to sugammadex.
Discussions for Patients Starting BELSOMRA® (suvorexant) C-IV
Dosing. Important things to discuss with patients starting BELSOMRA Recommend an adequate trial period. The way your patients feel when they fall asleep may be different from their previous experience or expectations 1; It may take a few nights to a week for your patients to assess the effect of BELSOMRA 2,3; In two 3-month clinical trials with BELSOMRA 15 mg and 20 mg, patients reported less